Clinical Trial Update: 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

View source ↗

Summary

Update on the 4-Repeat Tauopathy Neuroimaging Initiative Cycle 2 indicates the study status is completed. The listed conditions span corticobasal degeneration, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corticobasal Degeneration
• Nonfluent Variant Primary Progressive Aphasia
• Progressive Supranuclear Palsy

Snippet

Sponsor: University of California, San Francisco | Conditions: Corticobasal Degeneration (CBD), Corticobasal Syndrome (CBS) | Status: COMPLETED